Will we be able to beat cancer with technology? In any case, this is what Transgene expects with its additional solutions to conventional treatments. To this end, the Alsatian company has been working since 1979 in the world of biotechnology to develop immunotherapy treatments.
Various types of cancer are treated with these solutions, in particular cervical cancer, throat cancer and, more recently, lung cancer. “Immunotherapy is the new mainstay for treating patients. We complement other therapies to kill the disease and prevent it from coming back,” explains Hedi Ben Brahim, CEO of Transgene, a guest at Tech&Co.
artificial intelligence needed
The objective of these treatments is therefore to stimulate the immune system and educate it, thanks to a unique product created according to the patient and their type of cancer. One of the technologies works, for example, thanks to viruses.
Artificial intelligence, as in many areas now, is also used daily by Transgene to refine its technologies, particularly in the search for cancer cells.
The Alsatian company should also announce several scientific advances in the coming days. Always with the illusion of offering cancer patients the most viable and effective solutions.
Source: BFM TV
